logo

For the Inventor, By the Inventor

Thiais, France

Daniel Reisdorf

This inventor holds 18 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Rhone-Poulenc Industries, Rhone-Poulenc Rorer S.a., Institute Malgache De Recherches Appliquees. Active years: 1977-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Reisdorf. Retrieved from https://idiyas.com/inventor/daniel-reisdorf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 61(Granted Patents)


Location History:

  • Republique-Thiais, FR (1978)
  • Thiais, FR (1977 - 2001)

Company Filing History:

goldMedal14 out of 521 
 
Rhone-Poulenc Industries
 patents
silverMedal2 out of 247 
 
Rhone-Poulenc Rorer S.a.
 patents
bronzeMedal1 out of 1 
 
Institute Malgache De Recherches Appliquees
 patent
4. 2 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1977-2001

Loading Chart...
Areas of Expertise:
Sodium Oxamate
Eugenia Jambolana
Lupane Derivatives
Thiazolo Isoquinolines
Antiviral Compounds
Indole Derivatives
Daunorubicin
Thiazolothienopyridines
Naphthacene
Pharmaceutical Compositions
Isoquinoline
Medicaments
18 patents (USPTO):Explore Patents
1. 6300375 - Sodium oxamate for the treatment of diabetic conditions (2001-10-09),
2. 6194412 - Mixtures derived from grains of Eugenia Jambolana Lamarck preparation and use of said mixtures and some of their constituents as medicaments (2001-02-27),
3. 5972342 - Mixtures derived from grains of eugenia jambolana lamarck, preparation (1999-10-26),
4. 5468888 - Lupane derivatives, their preparation and the pharmaceutical (1995-11-21),
5. 4363909 - Thiazolo[3,4-b]isoquinolines (1982-12-14),
6. 4287197 - Antiviral isoquinoline derivatives (1981-09-01),
7. 4269842 - Method for treating rhinoviral complaints (1981-05-26),
8. 4261999 - Thiazolothienopyridines and anti-viral compositions thereof (1981-04-14),
9. 4261993 - Indole derivatives (1981-04-14),
10. 4261992 - Isoquinoline derivatives (1981-04-14),
11. 4225589 - Daunorubicin derivatives (1980-09-30),
12. 4189480 - Isoquinoline derivatives (1980-02-19),
13. 4185111 - Daunorubicin derivatives (1980-01-22),
14. 4153699 - Thiazolo[3,4-a]indole derivatives and pharmaceutical compositions (1979-05-08),
15. 4153698 - Isoquinoline derivatives and pharmaceutical compositions containing them (1979-05-08),

Title: The Innovations of Daniel Reisdorf

Introduction

Daniel Reisdorf is a notable inventor based in Thiais, France. He has made significant contributions to the field of medicine, particularly in the treatment of diabetic conditions. With a total of 18 patents to his name, Reisdorf's work has had a considerable impact on healthcare.

Latest Patents

Among his latest patents is the invention of Sodium oxamate for the treatment of diabetic conditions. This invention relates to mixtures that can be isolated from grains of Eugenia Jambolana Lamarck. The preparation of such mixtures, the medicaments containing these mixtures or their constituents, and the use of these mixtures for the preparation of a medicament are key aspects of this patent. Another significant patent involves mixtures derived from grains of Eugenia Jambolana Lamarck, focusing on their preparation and use as medicaments.

Career Highlights

Daniel Reisdorf has worked with prominent companies in the pharmaceutical industry, including Rhone-Poulenc Industries and Rhone-Poulenc Rorer S.A. His experience in these organizations has contributed to his expertise and innovative capabilities in developing new medical treatments.

Collaborations

Throughout his career, Reisdorf has collaborated with notable individuals such as Daniel Farge and Gerard Ponsinet. These collaborations have likely enriched his work and expanded the scope of his inventions.

Conclusion

Daniel Reisdorf's contributions to the field of medicine through his innovative patents demonstrate his commitment to improving healthcare. His work continues to influence the treatment of diabetic conditions and showcases the importance of research and development in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…